Paper Details
- Home
- Paper Details
Comparative effects of amlodipine and benazepril on left atrial pressure in dogs with experimentally-induced mitral valve regurgitation.
Author: FukushimaRyuji, HamabeLina, IshikawaTaisuke, KimSoomin, MachidaNoboru, SuzukiShuji, TanakaRyou, YamamotoYuta, YoshiyukiRieko
Original Abstract of the Article :
One of the purposes of treatment for dogs with mitral regurgitation (MR) is lowering left atrial pressure (LAP). There has been few study of the amlodipine in dogs with MR and amlodipine's effect on LAP has not been fully evaluated in a quantitative manner because of difficulties in directly measuri...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3489586/
データ提供:米国国立医学図書館(NLM)
A Race Against Time: Comparing Amlodipine and Benazepril for Mitral Regurgitation
Mitral regurgitation, a condition that can be like a leaky valve in the heart, like a failing water source in a desert oasis, can lead to increased left atrial pressure. This study, like a group of researchers racing against time to find the best treatment strategy for this condition, compares the effects of amlodipine and benazepril, two medications commonly used to treat hypertension, on left atrial pressure in dogs with experimentally induced mitral regurgitation. The researchers found that both medications effectively reduced left atrial pressure, highlighting the potential of these drugs to manage this challenging heart condition. This study provides valuable insights into the complex interplay of medications and heart health, emphasizing the importance of finding the right treatment strategy for each individual.A Lifeline in the Desert: Amlodipine and Benazepril for Mitral Regurgitation
This study, like a group of explorers searching for a solution to a pressing problem in the desert, highlights the potential of amlodipine and benazepril in managing mitral regurgitation. The researchers found that both medications effectively reduced left atrial pressure, offering a glimmer of hope for those struggling with this challenging heart condition. This study provides valuable insights into the complex interplay of medications and heart health, emphasizing the importance of finding the right treatment strategy for each individual, like choosing the right camel for a specific desert journey.Navigating the Desert of Heart Health: A Balanced Approach to Mitral Regurgitation
This study, like a guidebook offering valuable advice for navigating the treacherous landscape of heart health, provides important insights into the treatment of mitral regurgitation. The researchers found that both amlodipine and benazepril effectively reduced left atrial pressure, suggesting that these medications may be valuable tools for managing this challenging heart condition. It's important to remember that each patient's heart health journey is unique, and it's always a good idea to consult with your healthcare provider to discuss the most appropriate treatment strategy for your specific needs.Dr.Camel's Conclusion
This study, like a journey through a vast and challenging desert, highlights the potential of amlodipine and benazepril in managing mitral regurgitation. While more research is needed to fully understand the long-term effects of these medications, this study offers valuable insights into the complex interplay of medications and heart health, emphasizing the importance of a tailored approach to treatment.Date :
- Date Completed 2013-03-25
- Date Revised 2021-10-21
Further Info :
Related Literature
Article Analysis
SNS
PICO Info
in preparation
Languages
English
Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.